Results 111 to 120 of about 14,856,300 (187)

Secondary peripheral T-cell lymphoma in a patient with DLBCL harboring <i>BLM</i> mutation following CD19/CD22 bispecific CAR-T cell therapy. [PDF]

J Immunother Cancer
Liu X, Cong J, Xia X, Wang H, Yu X, Zheng Q, Wang L.   +6 more
europepmc   +1 more source

Clinical features and outcomes of peripheral T-cell lymphoma, not otherwise specified: A single institution retrospective analysis of 30 cases. [PDF]

Oncol Lett
Ma MX, Zhang YL, Xing LN, Wang QY, Qiao S.   +4 more
europepmc   +1 more source

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients? [PDF]

Ann Hematol
Lan Y, Zhao Y, Sun J, Zhou, Wang J, Zheng X, Shi Y, Meng H, Wei J, Yang C, Yu W, Jin J, Tong H, Xie W.   +13 more
europepmc   +1 more source

Successful Treatment of Peripheral T-cell Lymphoma Not Otherwise Specified in Bilateral Subconjunctiva: A Case Report. [PDF]

Cureus
Ota H, Arihiro K, Mihara K, Chikama TI.
europepmc   +1 more source

Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy. [PDF]

J Clin Exp Hematop
Saburi M, Nishikawa T, Maehara K, Takata H, Sakata M, Sasaki H, Abe M, Kohno K, Kusaba T, Urabe S, Kondo Y, Nakayama T, Ohtsuka E.   +12 more
europepmc   +1 more source

Daratumumab in combination with GDP chemotherapy in CD38-positive relapsed/refractory peripheral T-cell lymphoma: a phase 2 study of the Fondazione Italiana Linfomi. [PDF]

Ann Hematol
Ballerini M, Lucchini E, Ravano E, Rosa J, Patti C, Arcari A, Cavallo F, Ballotta L, Loseto G, Evangelista A, Tabanelli V, Zaja F.   +11 more
europepmc   +1 more source

Peripheral T-cell lymphoma in adult-onset familial hemophagocytic lymphohistiocytosis type 2 and heterozygous <i>LRBA</i> mutation. [PDF]

Haematologica
Tembrink M, Haverkamp T, Reinhardt HC, Hanoun M.   +3 more
europepmc   +1 more source

18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG PET/CT) in the Characterization of Massive Cardiac Infiltration by Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS). [PDF]

Cureus
Del Corral Vazquez RA, Schalch JM, Serna Macias JA, Murguia Lugo EF.   +3 more
europepmc   +1 more source

Rare case report and literature review of peripheral T-cell lymphoma presenting as massive gastrointestinal hemorrhage: an unusual etiology demanding emergency surgical intervention. [PDF]

Front Oncol
Liu Z, Zhang L, Chen Q, He H, Xiong Y, Peng W, Liu Y, Li G, Zhan L.   +8 more
europepmc   +1 more source

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study. [PDF]

Blood Adv
Tournilhac O, Bouabdallah K, Lecolant S, Hacini M, Laribi K, Bailly S, Belmondo T, Maerevoet M, Ysebaert L, Guidez S, Le Gouill S, Bonnet C, André M, Dupuis J, Thieblemont C, Bachy E, Daguindau N, Morschhauser F, Tricot S, Moulin C, Banos A, Houot R, Chauchet A, Gyan E, Cartron G, Farhat H, Camus V, Drenou B, Zerazhi H, Sibon D, Nicolas-Virelizier E, Delette C, Snauwaert S, Bailly S, Delarue R, Carras S, Ledoux-Pilon A, Parrens MC, Griolet S, Gaulard P, Delfau-Larue MH, de Leval L, Damaj GL.   +42 more
europepmc   +1 more source